Altimmune Inc (ALT)

SG&A Expenses

$32.04M

TTM · Period ending: · USD

ALT logo

ALT SG&A Expenses

Latest reported$32.04M
ALT TTM SG&A Expenses ($489.39K → $32.04M)
High-resolution chart · PNG

ALT sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Altimmune Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
32,040,000
30,157,000
28,098,000
22,678,000
21,743,000
21,647,000
20,966,000
20,208,000
19,753,000
18,918,000
18,137,000
17,610,000
17,588,000
17,238,000
17,134,000
17,106,000
16,769,999
16,018,999
15,412,999
15,747,928
15,812,167
14,698,523
13,209,440
11,112,333
9,079,756
8,766,217
8,500,782
8,905,890
8,681,962
9,384,127
9,765,539
8,939,384
10,014,407
8,874,934
9,655,630
13,233,500
13,909,491
13,550,363
11,515,071
7,319,215
4,835,503
5,219,363
6,222,185
7,868,332
9,829,724
10,430,392
10,911,724
12,870,101
13,764,022
13,676,843
13,279,186
11,323,597
10,512,677
10,960,046
11,628,732
11,682,815
11,690,633
12,319,906
14,311,079
17,022,901
16,917,543
17,629,993
18,015,761
19,270,602
22,317,582
22,612,008
22,432,586
20,528,677
19,106,999
19,864,807
19,397,530
19,932,845
18,280,549
13,106,493
8,519,998
3,402,382
354,139
455,214
489,391
423,625
370,759
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.